black prostate cancer - search results

Scientists develop new method for prostate cancer screening halving the number of harmless tumors detected, reducing unnecessary treatment.

Annual prostate-specific antigen (PSA) screening may have a greater impact on reducing prostate cancer-specific mortality in Black men than in White men.

The team observed that cancer survivors had a 42% higher risk of CVD than people without a cancer history.

A wider reach—in patients and data—promises better outcomes.

The researchers showed that men of African ancestry inherit about twice the prostate cancer risk on average compared to men of European ancestry. In contrast, men of Asian ancestry inherit about three-quarters the risk of their white counterparts.

The researchers found no notable differences in genetic variation that would impact the efficacy of current therapies for prostate cancer, such as treatment with PARP inhibitors targeting DNA repair genes, between the two groups of men.

Based on the most current data, approximately 14% of men will be diagnosed with prostate cancer at some point during their lifetime. If detected...

More than 20 years ago, the announcement of the completion of the first human genome was heralded, often breathlessly, as the dawn of a new age of medicine. But how far have we actually come in using an individual’s unique molecular make up to provide individually tailored care based on this information?

Good health is not solely determined by whether a person has access to quality healthcare. Rather, it can be affected by a range of situations that happen to people outside of the health system in their everyday life.

In a recent study, diagnostic mammography results varied across racial and ethnic groups, with the rate of diagnostic accuracy highest in non‐Hispanic white women and lowest in Hispanic women.